Source: Drug Store News

Coalesce: Sandoz acquires Coalesce

The acquisition of Coalesce is expected to help Sandoz build on its existing portfolio of respiratory medicines.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Dave Ahern's photo - CEO of Coalesce

CEO

Dave Ahern

CEO Approval Rating

90/100

Read more